NEW YORK (GenomeWeb News) – Genomic Health said Tuesday after the close of the market that sales for its flagship product, the Oncotype Dx breast cancer assay, swelled 81 percent for the second quarter ended June 30, 2008, and the firm cut its net loss 43 percent year over year.
 
Genomic Health reported total revenues of $27.8 million, up 89.1 percent from revenues of $14.7 million in the second quarter of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.